Novartis AG Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

11,131.13

11,608.16

11,896.11

11,540.46

11,110.53

11,316.96

10,342.70

Other Operating Income

0.00

Total Operating income

11,131.13

11,608.16

11,896.11

11,540.46

11,110.53

11,316.96

10,342.70

Raw Material Cost

2,829.00

2,741.39

2,900.99

2,916.48

2,809.91

2,869.94

2,706.99

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

224.88

238.70

242.72

241.29

228.74

222.50

193.23

Selling and Distribution Expenses

2,644.13

2,842.16

2,749.06

3,071.78

2,715.46

2,795.77

2,483.16

Other Expenses

206.71

192.20

188.33

199.35

183.25

187.59

178.63

Total Expenditure (Excl Depreciation)

7,765.14

7,744.28

7,776.12

8,223.01

7,586.66

7,764.13

7,169.68

Operating Profit (PBDIT) excl Other Income

3366

3863.8999999999996

4120

3317.5

3523.8999999999996

3552.7999999999997

3173

Other Income

291.30

416.29

131.25

328.15

421.96

294.86

15.74

Operating Profit (PBDIT)

4,664.85

5,238.29

5,285.06

5,074.01

5,648.41

4,898.71

4,337.66

Interest

224.88

238.70

242.72

241.29

228.74

222.50

193.23

Exceptional Items

-71.23

-296.52

-44.05

-519.42

-780.67

-149.24

-234.33

Gross Profit (PBDT)

8,302.13

8,866.77

8,995.12

8,623.98

8,300.62

8,447.02

7,635.71

Depreciation

1,007.56

958.12

1,033.82

1,428.41

1,702.58

1,051.02

1,148.90

Profit Before Tax

3,361.19

3,744.94

3,964.47

2,884.90

2,936.41

3,475.95

2,761.20

Tax

212.88

418.77

717.38

407.99

173.29

538.17

385.59

Provisions and contingencies

0.00

Profit After Tax

3,143.51

3,337.74

3,241.70

2,472.52

2,763.12

2,935.97

2,350.26

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3,143.51

3,337.74

3,241.70

2,472.52

2,763.12

2,935.97

2,350.26

Share in Profit of Associates

0.00

Minority Interest

1.60

-14.04

2.70

1.75

-3.47

0.00

Other related items

0.00

Consolidated Net Profit

3,145.11

3,323.70

3,244.39

2,474.27

2,759.65

2,935.97

2,350.26

Equity Capital

0.00

Face Value

0.0

Reserves

35,271.16

33,420.06

33,946.97

39,916.69

36,540.06

37,501.27

35,735.27

Earnings per share (EPS)

1.62

1.7

1.64

1.23

1.36

1.44

1.14

Diluted Earnings per share

1.62

1.7

1.64

1.23

1.36

1.44

1.14

Operating Profit Margin (Excl OI)

30.24%

33.29%

34.63%

28.75%

31.72%

31.39%

30.68%

Gross Profit Margin

39.25%

40.52%

42.02%

37.38%

41.75%

40.0%

37.81%

PAT Margin

28.24%

28.75%

27.25%

21.42%

24.87%

25.94%

22.72%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is -4.11% vs -2.42% in Jun 2025

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -5.37% vs 2.44% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -9.30% vs -6.44% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -5.78% vs -1.65% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Novartis AG With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CHF)

Change(%)

Net Sales

11,131.13

Other Operating Income

0.00

Total Operating income

11,131.13

Raw Material Cost

2,829.00

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

224.88

Selling and Distribution Expenses

2,644.13

Other Expenses

206.71

0.00

206.71

Total Expenditure (Excl Depreciation)

7,765.14

Operating Profit (PBDIT) excl Other Income

3,365.99

0.00

3,365.99

Other Income

291.30

Operating Profit (PBDIT)

4,664.85

Interest

224.88

Exceptional Items

-71.23

Gross Profit (PBDT)

8,302.13

Depreciation

1,007.56

Profit Before Tax

3,361.19

Tax

212.88

Provisions and contingencies

0.00

Profit After Tax

3,143.51

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3,143.51

Share in Profit of Associates

0.00

Minority Interest

1.60

Other related items

0.00

Consolidated Net Profit

3,145.11

Equity Capital

0.00

Face Value

0.00

Reserves

35,271.16

Earnings per share (EPS)

1.62

Diluted Earnings per share

1.62

Operating Profit Margin (Excl OI)

30.24%

0.00

30.24%

Gross Profit Margin

39.25%

0.00

39.25%

PAT Margin

28.24%

0.00

28.24%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,113.11 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -4.11% vs -2.42% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 0.19% vs 6.73% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 314.51 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -5.37% vs 2.44% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 13.97% vs 106.44% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 437.35 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -9.30% vs -6.44% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -16.32% vs -9.22% in Sep 2024

Quarterly - Interest

Interest 22.49 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -5.78% vs -1.65% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -1.66% vs 16.62% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 30.24%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024